Quốc gia: New Zealand
Ngôn ngữ: Tiếng Anh
Nguồn: Medsafe (Medicines Safety Authority)
Bendroflumethiazide 2.5mg; ;
Teva Pharma (New Zealand) Limited
Bendroflumethiazide 2.5 mg
2.5 mg
Tablet
Active: Bendroflumethiazide 2.5mg Excipient: Lactose Purified talc Starch Stearic acid
Blister pack, PVD/PVDC,, 14 tablets
Prescription
Prescription
Ipca Laboratories Limited
Bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.
Package - Contents - Shelf Life: Blister pack, PVD/PVDC, - 14 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVD/PVDC, - 28 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE, - 500 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE, - 1000 tablets - 24 months from date of manufacture stored at or below 25°C
2009-06-03
CONSUMER MEDICINE INFORMATION ARROW - BENDROFLUAZIDE BENDROFLUMETHIAZIDE 2.5 MG AND 5 MG TABLETS WHAT IS IN THIS LEAFLET Please read this leaflet carefully before you start taking ARROW-BENDROFLUAZIDE. This leaflet answers some common questions about ARROW-BENDROFLUAZIDE. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking ARROW-BENDROFLUAZIDE against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT ARROW - BENDROFLUAZIDE IS USED FOR ARROW-BENDROFLUAZIDE contains the active ingredient bendroflumethiazide, also known as bendrofluazide. ARROW-BENDROFLUAZIDE is a fluid tablet or diuretic. It helps reduce the amount of excess fluid in the body by increasing the amount of urine produced. It is used to treat swelling of the ankles, feet or legs, which is called oedema. This can occur in some heart, liver or kidney conditions. ARROW-BENDROFLUAZIDE is also used to treat high blood pressure either alone or in combination with other medicines. Your doctor may have prescribed ARROW-BENDROFLUAZIDE for another reason. Ask your doctor if you have any questions about why ARROW-BENDROFLUAZIDE has been prescribed for you. ARROW-BENDROFLUAZIDE is available only with a doctor’s prescription. BEFORE YOU TAKE ARROW-BENDROFLUAZIDE _WHEN YOU MUST NOT TAKE IT _ Do not take ARROW-BENDROFLUAZIDE if you have had an allergic reaction to bendroflumethiazide or any of the ingredients in ARROW-BENDROFLUAZIDE listed at the end of this leaflet. Some of the symptoms of an allergic reaction may include: • shortness of breath, wheezing or difficulty breathing • swelling of the face, lips, tongue or other parts of the body • lumpy skin rash ("hives"), hayfever or fainting. Do not take ARROW-BENDROFLUAZIDE if you have an allergy or have ev Đọc toàn bộ tài liệu
Version 1.3 Page 1 of 7 NEW ZEALAND DATA SHEET 1 NAME OF THE MEDICINE Arrow-Bendrofluazide 2.5, 2.5 mg, tablets Arrow-Bendrofluazide 5, 5 mg, tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 2.5 mg or 5 mg of bendroflumethiazide (also known as bendrofluazide). Excipient with known effect: lactose For the full list of excipients, see section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Tablets 2.5 mg: White to almost white, circular, biconvex, uncoated tablets. Tablets 5 mg: White to almost white, circular, flat, bevelled edged uncoated tablets with ‘5’ embossed on one side. Do not halve the tablets. Dose equivalence when the tablet is divided has not been established. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Bendroflumethiazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver. Bendroflumethiazide is indicated in the treatment of essential hypertension where it may be used as the sole antihypertensive agent, or as an adjunct to other medicines whose action it potentiates. 4.2 DOSE AND METHOD OF ADMINISTRATION ADULTS When bendroflumethiazide is added to other antihypertensive agents, the dosage of the latter can usually be reduced gradually as bendroflumethiazide takes effect. OEDEMA Initially 5 to 10 mg once daily or on alternate days. Maintenance: 2.5 to 10 mg two or three times weekly. 5 mg given orally once daily in the morning usually produces the desired effect without diuresis interfering with sleep, but this dose can be increased to 10 mg if required. During the first few days of treatment there is usually a large increase in urinary volume, which diminishes as treatment continues. ESSENTIAL HYPERTENSION 2.5 mg to 10 mg once daily, alone or in conjunction with other antihypertensive agents. Doses higher than 2.5 mg per day (for hypertension) are rarely necessary. ELDERLY The dosage of thiazide diuretics may need to be reduced in the elderly, particularly when renal functio Đọc toàn bộ tài liệu